Medicus Other Liab vs Total Stockholder Equity Analysis

MDCX Stock

USD 2.75 0.05 1.79%

Medicus Pharma financial indicator trend analysis is infinitely more than just investigating Medicus Pharma recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Medicus Pharma is a good investment. Please check the relationship between Medicus Pharma Other Liab and its Total Stockholder Equity accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medicus Pharma Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

Other Liab vs Total Stockholder Equity

Other Liab vs Total Stockholder Equity Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Medicus Pharma Other Liab account and Total Stockholder Equity. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Medicus Pharma's Other Liab and Total Stockholder Equity is -0.32. Overlapping area represents the amount of variation of Other Liab that can explain the historical movement of Total Stockholder Equity in the same time period over historical financial statements of Medicus Pharma Ltd, assuming nothing else is changed. The correlation between historical values of Medicus Pharma's Other Liab and Total Stockholder Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Liab of Medicus Pharma Ltd are associated (or correlated) with its Total Stockholder Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Stockholder Equity has no effect on the direction of Other Liab i.e., Medicus Pharma's Other Liab and Total Stockholder Equity go up and down completely randomly.

Correlation Coefficient

-0.32

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Other Liab

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Most indicators from Medicus Pharma's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Medicus Pharma current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medicus Pharma Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

Selling General Administrative is likely to rise to about 3 M in 2024

Medicus Pharma fundamental ratios Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Retained Earnings	Accounts Payable	Cash	Other Assets	Long Term Debt	Net Receivables	Inventory	Other Current Assets	Total Liab	Short Long Term Debt	Total Current Assets	Short Term Debt	Common Stock	Property Plant Equipment	Other Liab	Other Current Liab	Net Debt	Common Stock Shares Outstanding	Net Invested Capital	Capital Stock	Net Working Capital
Total Assets		-0.11	0.26	-0.74	-0.71	0.72	0.59	-0.58	-0.58	-0.58	-0.58	-0.58	-0.09	0.79	1.0	0.72	0.14	-0.58	-0.58	0.54	0.44	0.44	0.61	0.61	0.61
Total Current Liabilities	-0.11		-0.99	-0.05	0.11	0.01	-0.17	0.22	0.22	0.22	0.22	0.22	1.0	0.33	-0.11	0.02	0.57	0.22	0.22	-0.06	0.09	-0.17	-0.26	-0.24	-0.28
Total Stockholder Equity	0.26	-0.99		-0.05	-0.23	0.09	0.28	-0.32	-0.32	-0.32	-0.32	-0.32	-0.98	-0.19	0.27	0.08	-0.52	-0.32	-0.32	0.16	0.0	0.24	0.36	0.34	0.38
Net Tangible Assets	-0.74	-0.05	-0.05		0.06	-1.0	0.1	-0.07	-0.07	-0.07	-0.07	-0.07	-0.08	-0.43	-0.74	-1.0	0.23	-0.07	-0.07	0.09	0.1	0.05	0.07	0.08	0.07
Retained Earnings	-0.71	0.11	-0.23	0.06		-0.03	-0.98	0.94	0.94	0.94	0.94	0.94	0.11	-0.79	-0.71	-0.03	-0.54	0.94	0.94	-0.91	-0.79	-0.73	-0.97	-0.98	-0.95
Accounts Payable	0.72	0.01	0.09	-1.0	-0.03		-0.13	0.1	0.1	0.1	0.1	0.1	0.05	0.39	0.72	1.0	-0.29	0.1	0.1	-0.12	-0.13	-0.07	-0.1	-0.1	-0.1
Cash	0.59	-0.17	0.28	0.1	-0.98	-0.13		-0.95	-0.95	-0.95	-0.95	-0.95	-0.18	0.68	0.59	-0.13	0.53	-0.95	-0.95	0.92	0.78	0.72	0.99	1.0	0.98
Other Assets	-0.58	0.22	-0.32	-0.07	0.94	0.1	-0.95		1.0	1.0	1.0	1.0	0.23	-0.62	-0.58	0.1	-0.47	1.0	1.0	-0.76	-0.6	-0.9	-0.94	-0.95	-0.94
Long Term Debt	-0.58	0.22	-0.32	-0.07	0.94	0.1	-0.95	1.0		1.0	1.0	1.0	0.23	-0.62	-0.58	0.1	-0.47	1.0	1.0	-0.76	-0.6	-0.9	-0.94	-0.95	-0.94
Net Receivables	-0.58	0.22	-0.32	-0.07	0.94	0.1	-0.95	1.0	1.0		1.0	1.0	0.23	-0.62	-0.58	0.1	-0.47	1.0	1.0	-0.76	-0.6	-0.9	-0.94	-0.95	-0.94
Inventory	-0.58	0.22	-0.32	-0.07	0.94	0.1	-0.95	1.0	1.0	1.0		1.0	0.23	-0.62	-0.58	0.1	-0.47	1.0	1.0	-0.76	-0.6	-0.9	-0.94	-0.95	-0.94
Other Current Assets	-0.58	0.22	-0.32	-0.07	0.94	0.1	-0.95	1.0	1.0	1.0	1.0		0.23	-0.62	-0.58	0.1	-0.47	1.0	1.0	-0.76	-0.6	-0.9	-0.94	-0.95	-0.94
Total Liab	-0.09	1.0	-0.98	-0.08	0.11	0.05	-0.18	0.23	0.23	0.23	0.23	0.23		0.34	-0.09	0.05	0.56	0.23	0.23	-0.07	0.08	-0.17	-0.27	-0.24	-0.29
Short Long Term Debt	0.79	0.33	-0.19	-0.43	-0.79	0.39	0.68	-0.62	-0.62	-0.62	-0.62	-0.62	0.34		0.79	0.39	0.66	-0.62	-0.62	0.72	0.72	0.47	0.62	0.65	0.6
Total Current Assets	1.0	-0.11	0.27	-0.74	-0.71	0.72	0.59	-0.58	-0.58	-0.58	-0.58	-0.58	-0.09	0.79		0.72	0.14	-0.58	-0.58	0.54	0.44	0.45	0.61	0.61	0.61
Short Term Debt	0.72	0.02	0.08	-1.0	-0.03	1.0	-0.13	0.1	0.1	0.1	0.1	0.1	0.05	0.39	0.72		-0.28	0.1	0.1	-0.12	-0.13	-0.07	-0.1	-0.1	-0.09
Common Stock	0.14	0.57	-0.52	0.23	-0.54	-0.29	0.53	-0.47	-0.47	-0.47	-0.47	-0.47	0.56	0.66	0.14	-0.28		-0.47	-0.47	0.53	0.52	0.36	0.47	0.49	0.46
Property Plant Equipment	-0.58	0.22	-0.32	-0.07	0.94	0.1	-0.95	1.0	1.0	1.0	1.0	1.0	0.23	-0.62	-0.58	0.1	-0.47		1.0	-0.76	-0.6	-0.9	-0.94	-0.95	-0.94
Other Liab	-0.58	0.22	-0.32	-0.07	0.94	0.1	-0.95	1.0	1.0	1.0	1.0	1.0	0.23	-0.62	-0.58	0.1	-0.47	1.0		-0.76	-0.6	-0.9	-0.94	-0.95	-0.94
Other Current Liab	0.54	-0.06	0.16	0.09	-0.91	-0.12	0.92	-0.76	-0.76	-0.76	-0.76	-0.76	-0.07	0.72	0.54	-0.12	0.53	-0.76	-0.76		0.95	0.44	0.88	0.89	0.86
Net Debt	0.44	0.09	0.0	0.1	-0.79	-0.13	0.78	-0.6	-0.6	-0.6	-0.6	-0.6	0.08	0.72	0.44	-0.13	0.52	-0.6	-0.6	0.95		0.32	0.7	0.73	0.67
Common Stock Shares Outstanding	0.44	-0.17	0.24	0.05	-0.73	-0.07	0.72	-0.9	-0.9	-0.9	-0.9	-0.9	-0.17	0.47	0.45	-0.07	0.36	-0.9	-0.9	0.44	0.32		0.71	0.72	0.7
Net Invested Capital	0.61	-0.26	0.36	0.07	-0.97	-0.1	0.99	-0.94	-0.94	-0.94	-0.94	-0.94	-0.27	0.62	0.61	-0.1	0.47	-0.94	-0.94	0.88	0.7	0.71		1.0	1.0
Capital Stock	0.61	-0.24	0.34	0.08	-0.98	-0.1	1.0	-0.95	-0.95	-0.95	-0.95	-0.95	-0.24	0.65	0.61	-0.1	0.49	-0.95	-0.95	0.89	0.73	0.72	1.0		0.99
Net Working Capital	0.61	-0.28	0.38	0.07	-0.95	-0.1	0.98	-0.94	-0.94	-0.94	-0.94	-0.94	-0.29	0.6	0.61	-0.09	0.46	-0.94	-0.94	0.86	0.67	0.7	1.0	0.99

Click cells to compare fundamentals

Medicus Pharma Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Additional Tools for Medicus OTC BB Equity Analysis

When running Medicus Pharma's price analysis, check to measure Medicus Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medicus Pharma is operating at the current time. Most of Medicus Pharma's value examination focuses on studying past and present price action to predict the probability of Medicus Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medicus Pharma's price. Additionally, you may evaluate how the addition of Medicus Pharma to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Medicus Other Liab vs Total Stockholder Equity Analysis

Other Liab vs Total Stockholder Equity

Other Liab vs Total Stockholder Equity Correlation Analysis

Correlation Coefficient

Other Liab

Total Stockholder Equity

Medicus Pharma fundamental ratios Correlations

Medicus Pharma Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Also Currently Popular

Additional Tools for Medicus OTC BB Equity Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Current Liabilities
Short Term Debt	+ 1.0	Accounts Payable
Capital Stock	+ 1.0	Cash
Long Term Debt	+ 1.0	Other Assets
Net Receivables	+ 1.0	Other Assets

Short Term Debt	- 1.0	Net Tangible Assets
Accounts Payable	- 1.0	Net Tangible Assets
Total Stockholder Equity	- 0.99	Total Current Liabilities
Capital Stock	- 0.98	Retained Earnings
Cash	- 0.98	Retained Earnings
Total Liab	- 0.98	Total Stockholder Equity